Trials / Completed
CompletedNCT01710787
Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults
A Phase III, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Tetracaine Alone and to Placebo for Anesthetizing Maxillary Teeth in Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- St. Renatus, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of Kovacaine Mist, Tetracaine only, and Placebo for inducing pulpal anesthesia of the maxillary teeth in adults.
Detailed description
The study will employ a multi-center, randomized, double-blind, placebo-controlled, parallel-groups design to assess the safety and efficacy of Kovacaine Mist delivered intranasally for inducing pulpal anesthesia of maxillary teeth numbers 4 to 13 (maxillary right second premolar to maxillary left second premolar) sufficient to allow completion of the Study Dental Procedure. The intent is to treat 110 subjects, with enrollment balanced evenly between the 2 study sites, 2:2:1 randomization within each study site and an overall goal of 44 subjects treated with Kovacaine Mist, 44 treated with Tetracaine alone, and 22 treated with Placebo. Recruitment will be from diverse dental patient populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tetracaine HCl 3% and Oxymetazoline HCl 0.05% | 3 unilateral intranasal sprays per dose |
| DRUG | Tetracaine HCl 3% | 3 unilateral intranasal sprays per dose |
| DRUG | Placebo | 3 unilateral intranasal sprays per dose |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-10-19
- Last updated
- 2017-08-30
- Results posted
- 2017-08-30
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01710787. Inclusion in this directory is not an endorsement.